Neuraltus Pharmaceuticals Receives $17,000,000 Series A Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=309205c8-9d2a-4931-a10a-d8cb9f3620f6&Preview=1 -
Date
3/26/2009 -
Company Name
Neuraltus Pharmaceuticals -
Mailing Address
Undisclosed Menlo Park, CA 94025 -
Company Description
Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing innovative small molecule therapeutics for the treatment of neurodegenerative disorders. -
Website
http://www.neuraltus.com -
Transaction Type
Venture Equity -
Transaction Amount
$17,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Latterell Venture Partners -
Venture Investor
VantagePoint Venture Partners -
Venture Investor
Adams Street Partners
